SBS
The US Food and Drug Administration has approved Gilead’s lenacapavir, a twice-yearly injection for preventing HIV infection in adults and adolescents…
Read More
‘Milestone moment’: US approves twice-yearly HIV prevention jab Yeztugo
The US Food and Drug Administration has approved Gilead’s lenacapavir, a twice-yearly injection for preventing HIV infection in adults and adolescents…